May C - Search Results

1

Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.

Belur LR, James RI, May C, Diers MD, Swanson D, Gunther R, McIvor RS. Belur LR, et al. Among authors: may c. J Pharmacol Exp Ther. 2005 Aug;314(2):668-74. doi: 10.1124/jpet.104.082982. Epub 2005 Apr 27. J Pharmacol Exp Ther. 2005. PMID: 15857949

2

Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.

May C, Gunther R, McIvor RS. May C, et al. Blood. 1995 Sep 15;86(6):2439-48. Blood. 1995. PMID: 7662992 Free article.

3

Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.

May C, James RI, Gunther R, McIvor RS. May C, et al. J Pharmacol Exp Ther. 1996 Sep;278(3):1444-51. J Pharmacol Exp Ther. 1996. PMID: 8819532

4

Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.

James RI, May C, Vagt MD, Studebaker R, McIvor RS. James RI, et al. Among authors: may c. Exp Hematol. 1997 Nov;25(12):1286-95. Exp Hematol. 1997. PMID: 9357973

5

Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.

James R, May C, Diers M, Wagner J, McIvor R. James R, et al. Among authors: may c. Bone Marrow Transplant. 1999 Oct;24(8):815-21. doi: 10.1038/sj.bmt.1701984. Bone Marrow Transplant. 1999. PMID: 10516690

6

Interleukin-2 secretion by transduced and unselected BDL-2 lymphoma results in increased survival in mice with previously established disseminated disease.

Orchard PJ, Katsanis E, Boyer M, May C, McIvor RS, Blazar BR. Orchard PJ, et al. Among authors: may c. Cancer Biother Radiopharm. 1996 Apr;11(2):155-64. doi: 10.1089/cbr.1996.11.155. Cancer Biother Radiopharm. 1996. PMID: 10851532

7

From Genetic Findings to new Intestinal Molecular Targets in Lipid Metabolism.

May CL, Ducheix S, Cariou B, Rimbert A. May CL, et al. Curr Atheroscler Rep. 2025 Jan 11;27(1):26. doi: 10.1007/s11883-024-01264-w. Curr Atheroscler Rep. 2025. PMID: 39798054 Review.

8

Development of a non-specialist worker delivered psychological intervention to address alcohol use disorders and psychological distress among conflict-affected populations in Uganda and Ukraine.

Nadkarni A, Massazza A, Tol WA, Bogdanov S, Andersen LS, Moore Q, Roberts B, Weiss HA, Singh S, Neuman M, May C, Fuhr DC. Nadkarni A, et al. Among authors: may c. Int J Ment Health Syst. 2025 Jan 8;19(1):2. doi: 10.1186/s13033-024-00656-4. Int J Ment Health Syst. 2025. PMID: 39780252 Free PMC article.

9

G6PC2 controls glucagon secretion by defining the set point for glucose in pancreatic α cells.

Bahl V, Rifkind R, Waite E, Hamdan Z, May CL, Manduchi E, Voight BF, Lee MYY, Tigue M, Manuto N, Glaser B, Avrahami D, Kaestner KH. Bahl V, et al. Among authors: may cl. Sci Transl Med. 2025 Jan;17(779):eadi6148. doi: 10.1126/scitranslmed.adi6148. Epub 2025 Jan 1. Sci Transl Med. 2025. PMID: 39742505

10

Transfer of musculoskeletal care from paediatric to adult services for patients with cerebral palsy and chronic neuromuscular conditions: Identifying the unmet need.

Sagade B, Thorn C, Ross P, May C, Davies E, Rad D, Edwards C, Aarvold A. Sagade B, et al. Among authors: may c. Health Care Transit. 2024 Nov 2;2:100078. doi: 10.1016/j.hctj.2024.100078. eCollection 2024. Health Care Transit. 2024. PMID: 39712596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,765 results

Search Page

Filters